CHARLES SCHWAB INVESTMENT MANAGEMENT INC - NUVECTIS PHARMA INC ownership

NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 34 filers reported holding NUVECTIS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of NUVECTIS PHARMA INC
ValueSharesWeighting
Q3 2023$256,769
-10.7%
19,920
+10.7%
0.00%
Q2 2023$287,38017,9950.00%
Other shareholders
NUVECTIS PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ronit Capital LLP 550,000$4,076,0005.10%
Virtu Financial LLC 11,365$84,0000.01%
UBS Group AG 141$1,0000.00%
WELLS FARGO & COMPANY/MN 20$00.00%
GEODE CAPITAL MANAGEMENT, LLC 14,822$109,0000.00%
MILLENNIUM MANAGEMENT LLC 42,160$312,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
BlackRock Inc. 7,872$59,0000.00%
Tower Research Capital LLC (TRC) 1,750$13,0000.00%
View complete list of NUVECTIS PHARMA INC shareholders